Cargando…
Downregulation of miR-505-3p predicts poor bone metastasis-free survival in prostate cancer
The principal issue deriving from prostate cancer (PCa) is its propensity to metastasize to bone. To date, bone metastasis remains incurable, and therapeutic strategies are limited. Therefore, it is of paramount importance to explore predictive markers for bone metastasis of PCa. In the present stud...
Autores principales: | Tang, Yubo, Wu, Bowen, Huang, Shuai, Peng, Xinsheng, Li, Xing, Huang, Xiufang, Zhou, Wei, Xie, Peigen, He, Peiheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278553/ https://www.ncbi.nlm.nih.gov/pubmed/30365141 http://dx.doi.org/10.3892/or.2018.6826 |
Ejemplares similares
-
Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling
por: Tang, Yubo, et al.
Publicado: (2018) -
Downregulation of miR-19a-3p promotes invasion, migration and bone metastasis via activating TGF-β signaling in prostate cancer
por: Wa, Qingde, et al.
Publicado: (2018) -
Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling
por: Huang, Shuai, et al.
Publicado: (2018) -
Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer
por: Huang, Shuai, et al.
Publicado: (2017) -
miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2019)